(Q24243315)

30 October 2023

Munira Nurbhai

1

M

Nurbhai

1 reference

30 October 2023

Margaret Watson

3

M

Watson

1 reference

30 October 2023

Christine M Bond

4

0 references

Jill A Mollison

5

J

Mollison

1 reference

30 October 2023

Anne Ludbrook

6

A

Ludbrook

1 reference

30 October 2023

Cm Bond

Cm

Bond

4

1 reference

Cochrane Database of Systematic Reviews

30 October 2023

language of work or name

1 reference

17 October 2007

0 references

published in

0 references

cites work

A clinical multicenter study comparing efficacy and tolerability of topical combination therapy with clotrimazole (Canesten, two formats) with oral single dose fluconazole (Diflucan) in vulvovaginal mycoses

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002845.PUB2

Comparative study of the effectiveness of oral fluconazole and intravaginal clotrimazole in the treatment of vaginal candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002845.PUB2

An evaluation of butoconazole nitrate 2% site release vaginal cream (Gynazole-1) compared to fluconazole 150 mg tablets (Diflucan) in the time to relief of symptoms in patients with vulvovaginal candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002845.PUB2

Placebo-controlled trial of itraconazole for treatment of acute vaginal candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002845.PUB2

Language bias in randomised controlled trials published in English and German.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002845.PUB2

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002845.PUB2

Clinical and cost considerations in the pharmacotherapy of vulvovaginal candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002845.PUB2

Completeness of reporting of trials published in languages other than English: implications for conduct and reporting of systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002845.PUB2

Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002845.PUB2

Subverting randomization in controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002845.PUB2

A study of manufacturer-supported trials of nonsteroidal anti-inflammatory drugs in the treatment of arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002845.PUB2

7 January 2021

Single oral dose fluconazole compared with conventional clotrimazole topical therapy of Candida vaginitis. Fluconazole Vaginitis Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002845.PUB2

7 January 2021

A randomized, comparative study of a single oral dose of fluconazole versus a single topical dose of clotrimazole in the treatment of vaginal candidosis among general practitioners and gynaecologists

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002845.PUB2

7 January 2021

Prevalence of and risk factors for fungal vaginitis caused by non-albicans species

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002845.PUB2

7 January 2021

Candidal vulvovaginitis.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002845.PUB2

7 January 2021

Comparative study of fluconazole and clotrimazole for the treatment of vulvovaginal candidiasis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002845.PUB2

7 January 2021

A comparison of single-dose oral fluconazole with 3-day intravaginal clotrimazole in the treatment of vaginal candidiasis. Report of an international multicentre trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002845.PUB2

7 January 2021

Comparative study on the effectiveness of antifungal agents in different regimens against vaginal candidiasis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002845.PUB2

7 January 2021

Single-dose oral fluconazole versus single-dose topical miconazole for the treatment of acute vulvovaginal candidosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002845.PUB2

7 January 2021

Treatment of candidal vaginitis A prospective randomized investigator-blind multicenter study comparing topically applied econazole with oral fluconazole

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002845.PUB2

7 January 2021

10.1002/14651858.CD002845.PUB2

Identifiers

DOI

0 references

Fatcat ID

release_4tncohq3xjhrtmqoxbezepfxdy

0 references